Epidemiology of Fungal Diseases

Similar documents
Epidemiology and Laboratory Diagnosis of Fungal Diseases

Fungi. Eucaryotic Rigid cell wall(chitin, glucan) Cell membrane ergosterol Unicellular, multicellular Classic fungus taxonomy:

Epidemiology and ecology of fungal diseases

The Differentiation of Yeast and Yeast-Like Forms in Human Tissues. Introduction. Histochemical Stains Used to Detect Fungi. Histopathologic Diagnoses

HISTOPLASMOSIS - LABORATORY DIAGNOSIS IN VIETNAM

Lecture 7: Mycoses Caused by Dimorphic Fungi, Part I

North American Endemic Fungi

Potential etiologies of infection in these patients are diverse, including common and uncommon opportunistic infections.

Fungal update. Liise-anne Pirofski, M.D. Albert Einstein College of Medicine

Ali Alabbadi. Sarah Jaar ... Nader

Pneumocystis. Pneumocystis BIOL Summer Introduction. Mycology. Introduction (cont.) Introduction (cont.)

Fungi More or Less Obligately Associated with Humans. Requirements for Designating a Mycosis*

Fungal Infections. Fungal Infections

Fungal biology. Fungal Infections. Fungal cell structure. Pathogenesis

Fungi GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER NUMBER 53: Author Moi Lin Ling, MBBS, FRCPA, CPHQ, MBA

Fungal biology. Pathogenesis. Fungal cell structure. Fungal Infections MID 25 & 26. Eukaryotic (organized nucleus and cell structure) Non-motile

Medical Mycology. Dr. Hala Al Daghistani

Epidemiology of Nosocomial Fungal Infections

Mycobacteria and fungal infections of the respiratory tract

Medical Mycology. Dr. Hala Al Daghistani

Fungal infections in ICU. Tang Swee Fong Department of Paediatrics Universiti Kebangsaan Malaysia

Rheem Totah, Office H172M, Ph Office hours MWF 11:30 12:20 or by arrangement

Histopathology Description:

Overview of Microbiology. James D. Dick, PhD Johns Hopkins University

Second Joint Conference 0f the British HIV Association [BHIVA] and the British Association for Sexual Health and HIV [BASHH]

Update from the Laboratory: Clinical Identification and Susceptibility Testing of Fungi and Trends in Antifungal Resistance 13

Fungal Diseases of the Respiratory System

Histoplasmosis. Disease Etiology: Disease Transmission: Reservoirs: Specific Microbial Characteristics: By: Ernest Aguilar

Bloodborne Pathogens. Introduction to Fungi. Next >> COURSE 2 MODULE 4

A class IIa medical device intended for mild-to-moderate fungal nail infection PRODUCT MONOGRAPH

Introduction. Study of fungi called mycology.

Autopsy findings in 51 year-old man with mantle cell lymphoma

Reading material: MEDICAL MICROBIOLOGY

About the Editor Gerri S. Hall, Ph.D.

RESERVOIRS OF INFECTION

Mycotic Infections. A. The fungi represent a diverse, heterogeneous group of eukaryotic

8/2/10. Sanaz Jalali, Jennifer Demler, Jeremy King. Histoplasmosis is an intracellular mycotic infection of the reticuloendothelial system.

Mycology. BioV 400. Subcutaneous Mycoses. Ecological associations. Geographic distribution World-wide

L11 Fungal Infection SCBM341: GENERAL PATHOLOGY. Niwat Kangwanrangsan, Ph.D. Department of Pathobiology Faculty of Science, Mahidol University

Fungi are eukaryotic With rigid cell walls composed largely of chitin rather than peptidoglycan (a characteristic component of most bacterial cell

2046: Fungal Infection Pre-Infusion Data

Fungal infection in the immunocompromised patient. Dr Kirsty Dodgson

PRESENTER: DENNIS NYACHAE MOSE KENYATTA UNIVERSITY

number Done by Corrected by Doctor د.حامد الزعبي

Histoplasmosis. *resolution protective immunity. a 1 o "endemic" mycosis; 1 o "pulmonary" mycosis

ENG MYCO WELL D- ONE REV. 1.UN 29/09/2016 REF. MS01283 REF. MS01321 (COMPLETE KIT)

Fungi. CLS 311 Mrs. Ohoud alhumaidan

Dermatophytes Dr. Hala Al Daghistani

Candida auris: an Emerging Hospital Infection

Value o f Immunodiffusion Tests in the Diagnosis o f Systemic M ycotic Diseases

L11 Fungal Infection. Introduction. Outline. Fungi. Site of infection

Microbiology Collection

Conservation of morphogenesis and virulence in Cryptococcus neoformans. Xiaorong Lin Texas A&M University

Chapter 12. Characterizing and Classifying Eukaryotes. Part 2

Chapter 18. Fungal Diseases of the Lung. Mosby items and derived items 2011, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.

Fungal Infection Pre-Infusion Data

AST to ALT Ratio is elevated in disseminated histoplasmosis as compared to localized pulmonary disease and other endemic mycoses

The sensitivity of fungal microorganisms to fluconazole is as follows:

Paracoccidiomycosis and HIV/AIDS: A Common Problem in an Uncommon Location

VPM 201: Veterinary Bacteriology and Mycology 23-24/11/2011 LABORATORY 11: MYCOLOGY

New, Special Stain for Histopathological Diagnosis of Cryptococcosis

NATIONAL MYCOLOGY STRATEGIC PLANNING WORKSHOP

GAFFI Fact Sheet. Disseminated histoplasmosis

ECMM Excellence Centers Quality Audit

Current Status of Nonculture Methods for Diagnosis of Invasive Fungal Infections

Identification of Fungal Species in Proved Cases of Fungal Corneal Ulcer

Molecular phylogeny of Australian isolates of Sporothrix schenckii sensu lato. David New Microbiology Registrar, PathWest

Study of systemic fungal infections in renal transplant recipients

Antifungal Prophylaxis during Neutropenia and Immunodeficiency

Appropriate utilization of the microbiology laboratory. 11 April 2013

Trichophyton Microsporum Epidermophyton. dermatomycosis. Dematiaceous(pigmented fungi ) Dimorphic fungi Yeast and yeast like saprophyte

320 MBIO Microbial Diagnosis. Aljawharah F. Alabbad Noorah A. Alkubaisi 2017

Oral Candida biofilm model and Candida Staph interactions

Hepatitis E FAQs for Health Professionals

Staphylococci. Gram stain: gram positive cocci arranged in clusters.

WHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS?

CMV. Inclusions predominantly in endothelial cells. Immunostaining greater sensitivity than H&E alone.

Received 8 March 2001/Returned for modification 11 September 2001/Accepted 21 September 2001

ENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE

HOSPITAL INFECTION CONTROL

Microbiological diagnosis of infective endocarditis; what is new?

Histoplasma DxSelect. Enzyme-linked Immunosorbent Assay (ELISA) Product Code EL1700. Rev. E

Principles of Disease and Epidemiology Chapter 14. Biology 1009 Microbiology Johnson-Summer 2003

Cryptococcus gattii Fungal Meningitis. By Cassy Hedberg BI 234

Comparative In Vitro Antifungal Activity of Amphotericin B and Amphotericin B Methyl Ester

Fungal Infection Post-Infusion Data

Lab 4. Blood Culture (Media) MIC AMAL-NORA-ALJAWHARA 1

Candiduria in ICU : when and how to treat? Dr. Debashis Dhar Dept of Critical Care and Emergency Medicine Sir Ganga Ram Hospital

Current Options in Antifungal Pharmacotherapy

Only one take home point for the talk 9/26/2018. Infectious Diseases and Donor Derived Infections. Don t forget about donor-derived infections

Use of Antifungal Drugs in the Year 2006"

Histopathologic Diagnosis of Fungal Infections in the 21st Century

LESSON ASSIGNMENT. Introduction to Medical Mycology. After completing this lesson, you should be able to:

EMERGING FUNGAL INFECTIONS IN IMMUNOCOMPROMISED PATIENTS

Slide 1. Slide 2. Slide 3. What is injection safety Safe injection practices- Blood glucose monitoring Sharp safety.

VIRULENCE FACTORS AND SUSCEPTIBILITY OF CANDIDA SPP. CAUSATIVE AGENTS OF NEONATAL INFECTIONS

Acid-Fastness of Histoplasma in Surgical Pathology Practice

Case Studies in Fungal Infections and Antifungal Therapy

Common Fungi. Catherine Diamond MD MPH

by author CNS Difficult-to-treat fungal infections Campus Benjamin Franklin Dep. of Hematology and oncology PD Dr. Stefan Schwartz

Transcription:

Lecture 2 Epidemiology of Fungal Diseases Disclaimer: This lecture slide presentation is intended solely for educational purposes. Many of the images contained herein are the property of the original owner, as indicated within the figure itself or within the figure legend. These images are used only for illustrative purposes within the context of this lecture material. Use of these images outside the purpose of this presentation may violate the rights of the original owner. Dr. Cooper and Youngstown State University assume no responsibility for the unauthorized use of the material contained herein. Copyright 2010 Chester R. Cooper, Jr. Epidemiology of Mycoses Mycosis (pl., mycoses) - an infection caused by a fungus Two broad categories of mycoses Nosocomial (hospital acquired) Community acquired Nosocomial infections are considered opportunistic in origin Community-acquired infections can be opportunistic, but also include endemic mycoses Epidemiology of Mycoses (cont.) Epidemiology of Mycoses (cont.) Over the past 20 years, both nosocomial and community-acquired mycoses have increased dramatically Excluding HIV/AIDS patients, mycoses are the 7th most common cause of infectious disease Source: www.smrutilifesciences.com Contributing factors to increased mycoses: Growing population of immune compromised individuals Mobile population/immigration More older adults with chronic medical conditions Aggressive medical therapies Surgery Antibiotics Chemotherapies/Organ transplants Environmental changes Nosocomial Mycoses Between 1979 and 2000, the number of sepsis cases due to fungi increased 207% Between 1995 and 2002, 9.5% of bloodstream infections were due to fungi, of which the vast majority were Candida speces (the fourth leading cause of such infections) Yeasts of Candida. Source: doctorfungus.org From 1980 to 1990, a separate study noted a marked increase in nosocomial mycotic infections regardless of institution type Teaching hospitals Large (>500 beds): 2.4% to 6.6% Small (<500 beds): 2.1% to 3.5% Non-teaching hospitals Large (>200 beds): 1.2% to 2.5% Small (<200 beds): 0.9% to 2.4% Lecture 2: Fungal Epidemiology 1

These increases occurred regardless of: Body site (4 studied) Major specialty service provided Subspecialty service provided Deaths due to fungal infections increased nearly three-fold from 1980 (680 deaths) to 1990 (2300 deaths) Fungemia patients were more likely to die than those bloodstream infections by other types of microbes Independent risk factors for fungemia (i.e., those determined to enhance infection alone) Number and duration of antimicrobial agents Chemotherapy Previous colonization Indwelling catheter Neutropenia Hemodialysis Organ transplant patients experience the highest risk of fungal infection Rates of fungal infection by type of transplant Renal, <5% Bone marrow, 2-30% Heart, 10-35% Liver, 28-42% Risk factors include large corticosteroid doses, tissue rejection, poor tissue function, hyperglycemia, leukopenia, and age Molecular epidemiology Increased emphasis on characterizing pathogens at the subspecies level to: Better define infectious process Modes of transmission Classically, epidemiology was based upon physiological factors Today, epidemiological studies tend to be DNAbased using a variety of molecular methods Molecular methods include RFLP (restriction fragment length polymorphisms) analysis RFLPs of Candida species. Source: www.scielo.br/scielo.php? pid=s0037-86822006000200008&script=sci_arttext Lecture 2: Fungal Epidemiology 2

Molecular methods include RFLP (restriction fragment length polymorphisms) analysis Electrophoretic karyotyping Various satellite typing methods Protein-based methods include Immunoblot fingerprinting Polyacrylamide gel electrophoresis Multilocus enzyme electrophoresis Electrophoretic karyotypes of Candida albicans strains. Source: albicansmap.ahc.umn.edu Protein production (A) of rtbgs and immunoblot analsysis of the same protein (B). Source: Biochem. J. (2003) 373: 357-368 Key question asked by epidemiology - are two or more isolates associated with an outbreak the same or different? If different, probably reflect different sources or modes of infection If same, infection is assumed to be crosscontamination from one patient to another, or from a common source Typing methods can also help distinguish between a relapse of infection or the acquisition of an new one Epidemiology data can also be used to help develop strategies of prevention and control which must consider if the origin of infection is Endogenous - mainly yeast infections, particular Candida and Candida-like species Exogenous - mainly mold species, but also yeasts from contaminated sources Community-Acquired Mycoses Etiological agents of community-acquired fungal infections include Endemic dimorphic fungi Blastomyces dermatitidis Coccidioides immitis and C. posadasii Blastomyces dermatitidis mold and yeast phases (above) and dimorphism in Coccidioides immitis (below). Sources: botit.botany.wisc.edu/ toms_fungi/jan2001.html and www.vfce.arizona.edu/vfce%20old/valleyfever/canine/canine.htm Histoplasma capsulatum var. capsulatum and H. capsulatum var. dubosii Paracoccidioides brasiliensis Penicillium marneffei Mold and yeast phases of Histoplasm capsulatum. Sources: www.pgodoy.com/imicsistemi.htm and www.bact.wisc.edu/microtextbook/index.php? module=book&func=displayarticle&art_id=112 Lecture 2: Fungal Epidemiology 3

Opportunistic pathogens Candida species and other yeast and yeast-like fungi Non-pigmented (in vivo) molds causing hyalophyphomycosis Pigmented (in vivo) molds causing phaeohyphomycosis Subcutaneous pathogens causing sporotrichosis, chromoblastomycosis, and mycetoma Zygomycetes Endemic, dimorphic fungi Acquired in specific geographic regions Afflict both immune competent and immunocompromised individuals, but more common in HIV-infected persons and organ transplant recipients Endemic regions Histoplasma capsulatum var. capsulatum - Ohio River valley of the U.S. and Latin America var. dubosii - portions of Africa Coccidioides spp. - desert southwestern U.S., northern Mexico, and Central America Paracoccidioides brasiliensis. - Central and South America Blastomyces dermatitidis - Ohio River and Mississippi valley areas of U.S. and portions of Africa Penicillium marneffei - southeast Asia Source: doctorfungus.org Opportunistic fungal pathogens Includes virtually any fungus present in the environment Incidence is unknown because these types of infections are not required to be reported Among the most notable is Cryptococcus neoformans Rare infection prior to HIV pandemic Two varieties var. neoformans - worldwide distribution var. gattii - tropical and subtropical regions Laboratory Diagnosis Diagnosis of a fungal infection is complicated and requires diverse expertise Most common methods are traditional, i.e., isolation, culture, and observation Gold standard is the recovery of the etiological agent from the clinical specimen Current methods include a mixture of the traditional, commercially-available kits, and new molecular approaches Lecture 2: Fungal Epidemiology 4

A proper means to diagnosis includes the following: Specimen selection Proper anatomical site Use of suitable container for transport Specimen collection Choose an active lesion Use aseptic technique Obtain an appropriate quantity Use sterile, appropriately labeled containers Specimen transport and storage Examine microscopically as soon as possible Transport immediately using pertinent transport media if required Do not freeze specimens Do not refrigerate if not likely to contain contaminating microbes Do not desiccate Plate onto appropriate media Culture: most infectious agents identified growth from clinical specimens Media - various media have been developed, some quite traditional, and have been very successful in helping identify etiological agents Incubation conditions Optimal temperature: 30 C (range 25-30 C) Need a humid environment Incubation period of 4-6 weeks often used To assess form transitions, dimorphic fungi cultured at 35-37 C Direct microscopic examination Requires recovery and identification of fungus from cultures or examination of infected tissue Trained individual can often make diagnosis based upon this examination Types of observations Wet mounts (unstained) Stained preparations» Fungal cells» Tissue samples Methods of identification and diagnosis Morphology - some fungi exhibit characteristic cellular features both in vitro Histopathology - some fungi exhibit characteristic cellular features both in vitro Nucleic acid probes Serology Radiological surveys Lecture 2: Fungal Epidemiology 5